About Us
About Us
Focusing on the continuous innovation of diagnostic and treatment technologies for sleep, breathing disorders, and respiratory diseases, Resplev provides high-quality and innovative solutions for global users in the fields of pulmonary function testing, airway resistance management, oxygen therapy, and obstructive sleep apnea.
Headquartered in Suzhou Science and Technology City, Resplev has set up its production base in Suzhou, Wuzhong District, and Jiangning, Nanjing. The company has an independent R&D center, manufacturing plants and quality inspection department. Products have obtained registration and certification from NMPA, EU CE, and US FDA.
Relying on effective brand management collaboration with clinical, our independent products serve different treatment needs for different treatment phases. Resplev has successfully obtained cooperation from numerous academic, pharmacist, and industry organizations. Customers trust and recognize our brand internationally.
100+
Countries & Regions
70,000+
Clients Served
3,000,000+
Products Delivered
Qualification Advantages
Resplev has independent research and development, manufacturing, and quality inspection departments. Products have obtained registration and certification from NMPA, EU CE, and US FDA.
Team Advantages
Our core R&D, clinical and after-sales team has 10+ years of respiratory therapy experience, delivering one-on-one services to more than 1,000 users across the globe.
Technical Advantages
More than 30 independent intellectual property rights spanning appearance, structure, algorithm, and cloud interaction — driving continuous innovation in respiratory care.
Development History
Launched the B6 Series Products
New design strategy for development started. Resplev introduced its first generation of portable oxygen concentrators and established its global distribution network.
CE Certification Obtained
Products received CE marking approval, opening access to European markets and establishing Resplev as a globally recognized medical device manufacturer.
Sleep Treatment Line Launched
Resplev expanded into PAP ventilation therapy with the launch of its intelligent sleep treatment series, featuring adaptive pressure algorithms.
FDA Clearance & 70k Clients
Received US FDA clearance and crossed 70,000 clients served across 100+ countries and regions, cementing our position as a trusted global respiratory care brand.
Qualifications and Certificates
NMPA 23-11
NMPA 20-260
CE 20-200
CE 21-201